119 related articles for article (PubMed ID: 15064749)
1. Multiple functional domains of the oncoproteins Spi-1/PU.1 and TLS are involved in their opposite splicing effects in erythroleukemic cells.
Delva L; Gallais I; Guillouf C; Denis N; Orvain C; Moreau-Gachelin F
Oncogene; 2004 May; 23(25):4389-99. PubMed ID: 15064749
[TBL] [Abstract][Full Text] [Related]
2. Spi-1/PU.1 but not Fli-1 inhibits erythroid-specific alternative splicing of 4.1R pre-mRNA in murine erythroleukemia cells.
Théoleyre O; Deguillien M; Morinière M; Starck J; Moreau-Gachelin F; Morlé F; Baklouti F
Oncogene; 2004 Jan; 23(4):920-7. PubMed ID: 14647452
[TBL] [Abstract][Full Text] [Related]
3. Subtle distinct regulations of late erythroid molecular events by PI3K/AKT-mediated activation of Spi-1/PU.1 oncogene autoregulation loop.
Breig O; Théoleyre O; Douablin A; Baklouti F
Oncogene; 2010 May; 29(19):2807-16. PubMed ID: 20190819
[TBL] [Abstract][Full Text] [Related]
4. RNA splicing mediated by YB-1 is inhibited by TLS/CHOP in human myxoid liposarcoma cells.
Rapp TB; Yang L; Conrad EU; Mandahl N; Chansky HA
J Orthop Res; 2002 Jul; 20(4):723-9. PubMed ID: 12168660
[TBL] [Abstract][Full Text] [Related]
5. The transcription factor Spi-1/PU.1 interacts with the potential splicing factor TLS.
Hallier M; Lerga A; Barnache S; Tavitian A; Moreau-Gachelin F
J Biol Chem; 1998 Feb; 273(9):4838-42. PubMed ID: 9478924
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of the Spi-1/PU.1 oncogene induces the expression of TRIM10/HERF1, a key factor required for terminal erythroid cell differentiation and survival.
Blaybel R; Théoleyre O; Douablin A; Baklouti F
Cell Res; 2008 Aug; 18(8):834-45. PubMed ID: 18560381
[TBL] [Abstract][Full Text] [Related]
7. Oncogenic TLS/ERG and EWS/Fli-1 fusion proteins inhibit RNA splicing mediated by YB-1 protein.
Chansky HA; Hu M; Hickstein DD; Yang L
Cancer Res; 2001 May; 61(9):3586-90. PubMed ID: 11325824
[TBL] [Abstract][Full Text] [Related]
8. Spi-1 transgenic mice develop a clonal erythroleukemia which does not depend on p53 mutation.
Barnache S; Wendling F; Lacombe C; Denis N; Titeux M; Vainchenker W; Moreau-Gachelin F
Oncogene; 1998 Jun; 16(23):2989-95. PubMed ID: 9662331
[TBL] [Abstract][Full Text] [Related]
9. Deregulated expression of the PU.1 transcription factor blocks murine erythroleukemia cell terminal differentiation.
Rao G; Rekhtman N; Cheng G; Krasikov T; Skoultchi AI
Oncogene; 1997 Jan; 14(1):123-31. PubMed ID: 9010239
[TBL] [Abstract][Full Text] [Related]
10. PU.1: a crucial and versatile player in hematopoiesis and leukemia.
Kastner P; Chan S
Int J Biochem Cell Biol; 2008; 40(1):22-7. PubMed ID: 17374502
[TBL] [Abstract][Full Text] [Related]
11. Germ-line deletion of p53 reveals a multistage tumor progression in spi-1/PU.1 transgenic proerythroblasts.
Scolan EL; Wendling F; Barnache S; Denis N; Tulliez M; Vainchenker W; Moreau-Gachelin F
Oncogene; 2001 Sep; 20(39):5484-92. PubMed ID: 11571646
[TBL] [Abstract][Full Text] [Related]
12. Beta-catenin interacts with the FUS proto-oncogene product and regulates pre-mRNA splicing.
Sato S; Idogawa M; Honda K; Fujii G; Kawashima H; Takekuma K; Hoshika A; Hirohashi S; Yamada T
Gastroenterology; 2005 Oct; 129(4):1225-36. PubMed ID: 16230076
[TBL] [Abstract][Full Text] [Related]
13. The putative oncogene Spi-1: murine chromosomal localization and transcriptional activation in murine acute erythroleukemias.
Moreau-Gachelin F; Ray D; Mattei MG; Tambourin P; Tavitian A
Oncogene; 1989 Dec; 4(12):1449-56. PubMed ID: 2594367
[TBL] [Abstract][Full Text] [Related]
14. Direct association between PU.1 and MeCP2 that recruits mSin3A-HDAC complex for PU.1-mediated transcriptional repression.
Suzuki M; Yamada T; Kihara-Negishi F; Sakurai T; Oikawa T
Oncogene; 2003 Nov; 22(54):8688-98. PubMed ID: 14647463
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Friend cells proliferation by spi-1 antisense oligodeoxynucleotides.
Delgado MD; Hallier M; Meneceur P; Tavitian A; Moreau-Gachelin F
Oncogene; 1994 Jun; 9(6):1723-7. PubMed ID: 8183568
[TBL] [Abstract][Full Text] [Related]
16. Spi-1/PU.1 proto-oncogene induces opposite effects on monocytic and erythroid differentiation of K562 cells.
Delgado MD; Gutiérrez P; Richard C; Cuadrado MA; Moreau-Gachelin F; León J
Biochem Biophys Res Commun; 1998 Nov; 252(2):383-91. PubMed ID: 9826539
[TBL] [Abstract][Full Text] [Related]
17. Interaction between the homeodomain protein HOXC13 and ETS family transcription factor PU.1 and its implication in the differentiation of murine erythroleukemia cells.
Yamada T; Shimizu T; Suzuki M; Kihara-Negishi F; Nanashima N; Sakurai T; Fan Y; Akita M; Oikawa T; Tsuchida S
Exp Cell Res; 2008 Feb; 314(4):847-58. PubMed ID: 18076876
[TBL] [Abstract][Full Text] [Related]
18. Identification of DNA binding specificity for TLS.
Takahama K; Arai S; Kurokawa R; Oyoshi T
Nucleic Acids Symp Ser (Oxf); 2009; (53):247-8. PubMed ID: 19749353
[TBL] [Abstract][Full Text] [Related]
19. Kit-activating mutations cooperate with Spi-1/PU.1 overexpression to promote tumorigenic progression during erythroleukemia in mice.
Kosmider O; Denis N; Lacout C; Vainchenker W; Dubreuil P; Moreau-Gachelin F
Cancer Cell; 2005 Dec; 8(6):467-78. PubMed ID: 16338660
[TBL] [Abstract][Full Text] [Related]
20. Isolation and characterization of a chicken homologue of the Spi-1/PU.1 transcription factor.
Kherrouche Z; Beuscart A; Huguet C; Flourens A; Moreau-Gachelin F; Stehelin D; Coll J
Oncogene; 1998 Mar; 16(10):1357-67. PubMed ID: 9546438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
